Press Releases

Press Releases

Morphic to Present at 2022 Jefferies Global Healthcare Conference

June 9, 2022
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Bruce Rogers, Ph.D., President of Morphic, will give a
Displaying 1 - 10 of 13